ArticleMolecular and clinical oncology2024

Efficacy and safety of second‑generation FLT3 inhibitors in acute myeloid leukemia: A systematic review and meta‑analysis of randomized controlled trials.

Wei-Ting Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.